Li, Q.; Luo, J.; Fu, C.; Kang, W.; Wang, L.; Tong, H.; Lun, Z.; Zhang, Q.; Lai, D.; Liu, H.
Discovery of Novel CRK12 Inhibitors for the Treatment of Human African Trypanosomiasis: An Integrated Computational and Experimental Approach. Pharmaceuticals 2025, 18, 778.
https://doi.org/10.3390/ph18060778
AMA Style
Li Q, Luo J, Fu C, Kang W, Wang L, Tong H, Lun Z, Zhang Q, Lai D, Liu H.
Discovery of Novel CRK12 Inhibitors for the Treatment of Human African Trypanosomiasis: An Integrated Computational and Experimental Approach. Pharmaceuticals. 2025; 18(6):778.
https://doi.org/10.3390/ph18060778
Chicago/Turabian Style
Li, Qin, Jiayi Luo, Chenggong Fu, Wenqingqing Kang, Lingling Wang, Henry Tong, Zhaorong Lun, Qianqian Zhang, Dehua Lai, and Huanxiang Liu.
2025. "Discovery of Novel CRK12 Inhibitors for the Treatment of Human African Trypanosomiasis: An Integrated Computational and Experimental Approach" Pharmaceuticals 18, no. 6: 778.
https://doi.org/10.3390/ph18060778
APA Style
Li, Q., Luo, J., Fu, C., Kang, W., Wang, L., Tong, H., Lun, Z., Zhang, Q., Lai, D., & Liu, H.
(2025). Discovery of Novel CRK12 Inhibitors for the Treatment of Human African Trypanosomiasis: An Integrated Computational and Experimental Approach. Pharmaceuticals, 18(6), 778.
https://doi.org/10.3390/ph18060778
